Non-ICANS neurotoxicities CD19-directed CAR T-cell therapy and the emergence of movement and neurocognitive treatment-emergent adverse events: a case report. - Schroeder T; Chitadze G; Dargvainiene J; Martens T; Gebauer N; Frimmel J; Brüggemann M; Valerius T; Schub N; Baldus CD; Pott C; Leypoldt F; et al. (Frontiers in immunology, 2026)